Annual Information Update

Phytopharm PLC
01 February 2008


                                 Phytopharm plc


                           Annual Information Update


Phytopharm plc (the Company) announces that, in accordance with the requirements
of Prospectus Rule 5.2 issued by the Financial Services Authority, and following
publication of the Annual Report on 16 January 2008, the following information
has been published or made available to the public between 13 January 2007 and 1
February 2008 inclusive, in compliance with laws and rules dealing with the
regulation of securities, issuers of securities and securities markets.

For the purpose of this update, only references to the information are provided.
Full copies of each item can be found at the locations specified below. In
accordance with the provisions of Article 27.3 of the Prospectus Directive
Regulations, we confirm that to the best of our knowledge, information relating
to 'Holdings in Company' and 'Director/PDMR Shareholdings' is up to date at the
date of this announcement, but it is acknowledged that such disclosures may, at
any time, become out of date, due to changing circumstances.
     
1.   Announcements made via Regulatory Information Services

     All documents listed below were published via a regulatory information 
     service on the dates indicated:


Date of publication       Title

21 January 2008           $1.16m funding for Cogane(TM)
16 January 2008           Publication of 2007 annual report and accounts
10 January 2008           Director/PDMR shareholding
2 January 2008            Total Voting rights
14 December 2007          Director/PDMR shareholding
4 December 2007           Total Voting Rights
29 November 2007          Second price monitoring extension
29 November 2007          Price monitoring extension
29 November 2007          Final Results
27 November 2007          Holding in Company
23 November 2007          Appointment of Adviser
9 November 2007           Director/PDMR shareholding
29 October 2007           Block Listing Cancellation
29 October 2007           Additional Listing
3 October 2007            New Accounting Reference Date
24 September 2007         Joint Development Agreement
18 September 2007         Block Listing Interim Review
14 September 2007         Director/PDMR shareholding
14 September 2007         Director/PDMR shareholding
6 August 2007             Director/PDMR shareholding
6 August 2007             Director/PDMR shareholding
30 July 2007              Research Update
26 June 2007              Collaboration & Licence Agreement
20 June 2007              Notification of Board change
14 June 2007              Result of EGM
11 June 2007              Holding(s) in company
7 June 2007               Director/PDMR shareholding
5 June 2007               Research Update
22 May 2007               Notification of EGM
17 May 2007               Research Update
9 May 2007                Director/PDMR shareholding
9 May 2007                Director/PDMR shareholding
9 May 2007                Director/PDMR shareholding
9 May 2007                Director/PDMR shareholding
1 May 2007                Block Listing Interim Review
1 May 2007                Interim results
24 April 2007             Price Monitoring Extension
20 April 2007             Notice of results
16 April 2007             Product Launch
2 April 2007              Total Voting Rights
29 March 2007             Result of AGM
26 March 2007             Product Launch
19 March 2007             Block Listing Interim Review
7 March 2007              Holding(s) in company
7 March 2007              Holding(s) in company
2 March 2007              Notification of AGM
1 March 2007              Second price monitoring extension
1 March 2007              Price monitoring extension
1 March 2007              Placing of New Ordinary Shares
15 January 2007           Price monitoring extension
15 January 2007           Annual Information Update 

         
2.   Documents published or sent to Shareholders or filed with the UK Listing
     Authority or submitted to the FSA

16 January 2008     Annual Report 2007
29 October 2007     Application for admission of securities to the Official List
29 October 2007     Form 1 Application for admission of securities to trading
22 May 2007         Notice of Extraordinary General Meeting
18 May 2007         Interim Report 2007
2 March 2007        Application for admission of securities to the Official List
2 March 2007        Form 1 Application for admission of securities to trading
2 March 2007        Notice of Annual General Meeting

Certain documents submitted to the FSA can be viewed at the Document Viewing
Facility situated at the Financial Services Authority, 25 The North Colonade,
Canary Wharf, London E14 5HS

The Interim and Annual reports are also available on the Company's website
www.phytopharm.com
     
3.   Documents filed at Companies House

The Company has submitted the following filings to Companies House:

9 January 2008          Form 88(2) - Return of Allotment of Shares
17 December 2007        Form 363 Annual Return
11 December 2007        Form 88(2) - Return of Allotment of Shares
9 November 2007         Form 88(2) - Return of Allotment of Shares
3 October 2007          Form 225 - Change of Accounting Date
31 July 2007            Form 288(a) Appointment of Director - Mr Alistair Taylor
31 July 2007            Form 288(b) Terminating appointment of Director - 
                        Dr Paul Whitney
14 June 2007            Registration of resolutions passed at EGM and adoption 
                        of Articles of Association adopted at EGM
28 March 2007           Registration of resolutions passed at AGM
7 March 2007            Form 88(2) - Return of Allotment of Shares

Copies of these documents can be obtained from Companies House, Crown Way,
Cardiff CF14 3UZ (Telephone [phone], email at enquiries
@companies-house.gov.uk) or, if you are a registered user, through Companies
House Direct at www.companies-house.gov.uk

Copies of all documents referred to above are also available for inspection at
the Company's registered office (Corpus Christi House, 9 West Street,
Godmanchester, Cambs PE29 2HY, United Kingdom) during normal business hours or
by request from the Company Secretary.

For further information, please contact:

Zoe McGowan, Company Secretary

Phytopharm plc Tel No: [phone]

Further information about Phytopharm can be found on the Company's website
www.phytopharm.com


                      This information is provided by RNS
            The company news service from the London Stock Exchange           AFEFPPEFE